World Health Assembly adopts drug price transparency resolution

Countries will be more likely to require manufacturers to disclose drug prices and costs associated with their development and commercialization, after an agreement

Read the full 239 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE